Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer’s disease ; volume:56 ; number:2 ; day:9 ; month:2 ; year:2024 ; pages:301-310 ; date:2.2024
Experimental & molecular medicine ; 56, Heft 2 (9.2.2024), 301-310, 2.2024
- Creator
-
Choi, Byung Jo
Park, Min Hee
Jin, Hee Kyung
Bae, Jae-sung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-024-01176-4
- URN
-
urn:nbn:de:101:1-2405052122021.457079648860
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choi, Byung Jo
- Park, Min Hee
- Jin, Hee Kyung
- Bae, Jae-sung
- SpringerLink (Online service)
Other Objects (12)
Pathological phenotypes of astrocytes in Alzheimer’s disease
BrightFocus Alzheimer’s Fast Track 2019
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Pharmakologische Intervention der sauren Sphingomyelinase im Mausmodell der Alzheimer-Erkrankung
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Einfluss der sauren Sphingomyelinase auf die Makrophagenaktivierung durch Alzheimer Amyloid Protein
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Pathological phenotypes of astrocytes in Alzheimer’s disease
BrightFocus Alzheimer’s Fast Track 2019
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Pharmakologische Intervention der sauren Sphingomyelinase im Mausmodell der Alzheimer-Erkrankung
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Einfluss der sauren Sphingomyelinase auf die Makrophagenaktivierung durch Alzheimer Amyloid Protein
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Pathological phenotypes of astrocytes in Alzheimer’s disease
BrightFocus Alzheimer’s Fast Track 2019
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Pharmakologische Intervention der sauren Sphingomyelinase im Mausmodell der Alzheimer-Erkrankung
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Einfluss der sauren Sphingomyelinase auf die Makrophagenaktivierung durch Alzheimer Amyloid Protein
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?